AI assistant
Aptevo Therapeutics Inc. — Director's Dealing 2017
May 23, 2017
35422_dirs_2017-05-23_b035f547-29a3-484f-9def-6d7fa72e82ff.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Aptevo Therapeutics Inc. (APVO)
CIK: 0001671584
Period of Report: 2017-05-22
Reporting Person: White Marvin L (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-05-22 | Common Stock | M | 35643 | — | Acquired | 48504 | Direct |
| 2017-05-22 | Common Stock | M | 17828 | — | Acquired | 66332 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-05-22 | Restricted Stock Unit | $ | M | 35643 | Disposed | Common Stock (35643) | Direct | |
| 2017-05-22 | Restricted Stock Unit | $ | M | 17828 | Disposed | Common Stock (17828) | Direct |
Footnotes
F1: Each RSU converts into the Issuer's common stock on a one-for-one basis.
F2: The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on May 21, 2015. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the "Spin-off"), each RSU was adjusted and assumed by the Issuer. The RSUs vest in three equal annual installments beginning on the first anniversary of the grant date.
F3: The RSUs were originally issued by Emergent on May 22, 2014 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs fully vested on May 22, 2017.